More than 2,000 drugs now in cancer immunotherapy race | | LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development. |
| |
| | | | | | Related Video |
| | | | | | | | | | A quick-fix on the day's news delivered when you want it. Register Today | |
| | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | |
| | » » MORE NEWSLETTERS | |
|